173 related articles for article (PubMed ID: 18762216)
1. Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents.
Morrey JD; Taro BS; Siddharthan V; Wang H; Smee DF; Christensen AJ; Furuta Y
Antiviral Res; 2008 Dec; 80(3):377-9. PubMed ID: 18762216
[TBL] [Abstract][Full Text] [Related]
2. Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.
Morrey JD; Day CW; Julander JG; Blatt LM; Smee DF; Sidwell RW
Antivir Chem Chemother; 2004 Mar; 15(2):101-9. PubMed ID: 15185728
[TBL] [Abstract][Full Text] [Related]
3. Viral RNA-Dependent RNA Polymerase Inhibitor 7-Deaza-2'-
Eyer L; Fojtíková M; Nencka R; Rudolf I; Hubálek Z; Ruzek D
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30642926
[TBL] [Abstract][Full Text] [Related]
4. Humanized monoclonal antibody against West Nile virus envelope protein administered after neuronal infection protects against lethal encephalitis in hamsters.
Morrey JD; Siddharthan V; Olsen AL; Roper GY; Wang H; Baldwin TJ; Koenig S; Johnson S; Nordstrom JL; Diamond MS
J Infect Dis; 2006 Nov; 194(9):1300-8. PubMed ID: 17041857
[TBL] [Abstract][Full Text] [Related]
5. Defining limits of treatment with humanized neutralizing monoclonal antibody for West Nile virus neurological infection in a hamster model.
Morrey JD; Siddharthan V; Olsen AL; Wang H; Julander JG; Hall JO; Li H; Nordstrom JL; Koenig S; Johnson S; Diamond MS
Antimicrob Agents Chemother; 2007 Jul; 51(7):2396-402. PubMed ID: 17452485
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of Tissue-Specific CD8
Aguilar-Valenzuela R; Netland J; Seo YJ; Bevan MJ; Grakoui A; Suthar MS
J Virol; 2018 May; 92(10):. PubMed ID: 29514902
[TBL] [Abstract][Full Text] [Related]
7. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis.
Xiao SY; Guzman H; Zhang H; Travassos da Rosa AP; Tesh RB
Emerg Infect Dis; 2001; 7(4):714-21. PubMed ID: 11585537
[TBL] [Abstract][Full Text] [Related]
8. Modeling hamsters for evaluating West Nile virus therapies.
Morrey JD; Day CW; Julander JG; Olsen AL; Sidwell RW; Cheney CD; Blatt LM
Antiviral Res; 2004 Jul; 63(1):41-50. PubMed ID: 15196819
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment of adenosine nucleoside inhibitor NITD008 and histone deacetylase inhibitor vorinostat represents an immunotherapy strategy to ameliorate West Nile virus infection.
Nelson J; Roe K; Orillo B; Shi PY; Verma S
Antiviral Res; 2015 Oct; 122():39-45. PubMed ID: 26225754
[TBL] [Abstract][Full Text] [Related]
10. West Nile Virus-Inclusive Single-Cell RNA Sequencing Reveals Heterogeneity in the Type I Interferon Response within Single Cells.
O'Neal JT; Upadhyay AA; Wolabaugh A; Patel NB; Bosinger SE; Suthar MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626670
[TBL] [Abstract][Full Text] [Related]
11. Treatment of spatial memory impairment in hamsters infected with West Nile virus using a humanized monoclonal antibody MGAWN1.
Smeraski CA; Siddharthan V; Morrey JD
Antiviral Res; 2011 Jul; 91(1):43-9. PubMed ID: 21554903
[TBL] [Abstract][Full Text] [Related]
12. Increased blood-brain barrier permeability is not a primary determinant for lethality of West Nile virus infection in rodents.
Morrey JD; Olsen AL; Siddharthan V; Motter NE; Wang H; Taro BS; Chen D; Ruffner D; Hall JO
J Gen Virol; 2008 Feb; 89(Pt 2):467-473. PubMed ID: 18198377
[TBL] [Abstract][Full Text] [Related]
13. MAVS Expressed by Hematopoietic Cells Is Critical for Control of West Nile Virus Infection and Pathogenesis.
Zhao J; Vijay R; Zhao J; Gale M; Diamond MS; Perlman S
J Virol; 2016 Aug; 90(16):7098-7108. PubMed ID: 27226371
[TBL] [Abstract][Full Text] [Related]
14. Cellular microRNA-155 Regulates Virus-Induced Inflammatory Response and Protects against Lethal West Nile Virus Infection.
Natekar JP; Rothan HA; Arora K; Strate PG; Kumar M
Viruses; 2019 Dec; 12(1):. PubMed ID: 31861621
[TBL] [Abstract][Full Text] [Related]
15. Treatment of late stage disease in a model of arenaviral hemorrhagic fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin.
Gowen BB; Smee DF; Wong MH; Hall JO; Jung KH; Bailey KW; Stevens JR; Furuta Y; Morrey JD
PLoS One; 2008; 3(11):e3725. PubMed ID: 19008960
[TBL] [Abstract][Full Text] [Related]
16. High clonality of virus-specific T lymphocytes defined by TCR usage in the brains of mice infected with West Nile virus.
Kitaura K; Fujii Y; Hayasaka D; Matsutani T; Shirai K; Nagata N; Lim CK; Suzuki S; Takasaki T; Suzuki R; Kurane I
J Immunol; 2011 Oct; 187(8):3919-30. PubMed ID: 21908734
[TBL] [Abstract][Full Text] [Related]
17. Induction of virus-specific effector immune cell response limits virus replication and severe disease in mice infected with non-lethal West Nile virus Eg101 strain.
Kumar M; Roe K; O'Connell M; Nerurkar VR
J Neuroinflammation; 2015 Sep; 12():178. PubMed ID: 26392176
[TBL] [Abstract][Full Text] [Related]
18. Antibody prophylaxis and therapy against West Nile virus infection in wild-type and immunodeficient mice.
Engle MJ; Diamond MS
J Virol; 2003 Dec; 77(24):12941-9. PubMed ID: 14645550
[TBL] [Abstract][Full Text] [Related]
19. West Nile virus neutralization by US plasma-derived immunoglobulin products.
Planitzer CB; Modrof J; Kreil TR
J Infect Dis; 2007 Aug; 196(3):435-40. PubMed ID: 17597458
[TBL] [Abstract][Full Text] [Related]
20. Neurological suppression of diaphragm electromyographs in hamsters infected with West Nile virus.
Morrey JD; Siddharthan V; Wang H; Hall JO; Motter NE; Skinner RD; Skirpstunas RT
J Neurovirol; 2010 Jul; 16(4):318-29. PubMed ID: 20632796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
